CST3 and amyotrophic lateral sclerosis: In 2012, Tetssuka et al. [7] proposed that the serum creatinine to serum cystatin C ratio (CCR) could be used as an indicator to evaluate the severity of amyotrophic lateral sclerosis (ALS).